Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
BMC Cancer
|
April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Cancers
|
February 13, 2025
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology
Sean Ewings, Nadia Peppa, Daniel Griffiths, et al.
Human Pathology
|
May 12, 2012
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems
Runjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
Eclinicalmedicine
|
July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
Somnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
Somnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Eclinicalmedicine
|
October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
Christopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
Katy J McCann, Ann Mander, Angelica Cazaly, et al.
Arthritis and Rheumatism
|
July 27, 2012
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
Maxime Samson, Sylvain Audia, Jennifer Fraszczak, et al.
Age and Ageing
|
January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial
Robert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
BMC Cancer
|
April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Cancers
|
February 13, 2025
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology
Sean Ewings, Nadia Peppa, Daniel Griffiths, et al.
Human Pathology
|
May 12, 2012
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems
Runjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
Eclinicalmedicine
|
July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
Somnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
Somnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Eclinicalmedicine
|
October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
Christopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
Katy J McCann, Ann Mander, Angelica Cazaly, et al.
Arthritis and Rheumatism
|
July 27, 2012
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
Maxime Samson, Sylvain Audia, Jennifer Fraszczak, et al.
Age and Ageing
|
January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial
Robert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Page
of 12